Author Archives: admin

New Approach Which Can Help To Predict Neurodegenerative Diseases

New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America…

Posted in News from Other Sources | Comments closed

Study Probes Oxidative Stress in People with ALS

Participants are being sought for a 12-center study that will follow people with ALS over time to examine relationships between the disease and oxidative stress.

Posted in News from Other Sources | Comments closed

‘Power for the Journey’ Gives Back to ALS Community

Part support group, part fundraising effort, this group seeks to fuel ALS research while offering comfort to those who are coping with the disease.

Posted in News from Other Sources | Comments closed

Utah Researchers Seek CMD Families

Families affected by Ullrich congenital MD or Bethlem myopathy are invited to help with data collection at the University of Utah.

Posted in News from Other Sources | Comments closed

Nonwalkers with SMA at High Risk for Weight Gain

Study finds that children and adults with SMA who can’t walk but otherwise have good motor function are at risk for becoming overweight.

Posted in News from Other Sources | Comments closed

AVI BioPharma Announces Presentations On Exon Skipping Drug AVI-4658 For Treatment Of Duchenne Muscular Dystrophy

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, announced upcoming presentations on AVI-4658, the Company’s exon skipping therapy for the treatment of Duchenne muscular dystrophy, at the XII International Congress on Neuromuscular Diseases taking place July 17-22, 2010 in Naples, Italy…

Posted in News from Other Sources | Comments closed

New Way To Grow Adult Stem Cells In Culture May Lead To Treatment For Muscular Dystrophy

Researchers at the Stanford University School of Medicine have developed a technique they believe will help scientists overcome a major hurdle to the use of adult stem cells for treating muscular dystrophy and other muscle-wasting disorders that accompany aging or disease: They’ve found that growing muscle stem cells on a specially developed synthetic matrix that mimics the ela…

Posted in News from Other Sources | Comments closed

Antisense Treatment Restores Full-Length SMN in SMA Mice

Mice with a disease resembling type 3 SMA received infusions directly into the brain of a type of molecule known as a synthetic antisense oligonucleotide.

Posted in News from Other Sources | Comments closed

AVI BioPharma Opens Investigational New Drug (IND) Application For AVI-4658 In Duchenne Muscular Dystrophy

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, announced that following review by the U.S. Food and Drug Administration the Company’s Investigational New Drug (IND) application for AVI-4658 is open…

Posted in News from Other Sources | Comments closed

Of Mice and Men: ALS TDI Discusses ALS Research Animals

Animal models play a key role in ALS research, but their usage can be tricky, said ALS TDI in its recent public webinar.

Posted in News from Other Sources | Comments closed

  • Donate
  • Congenital Muscular Dystrophy

    A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...
  • Register Now!
  • Events

  • Register Now!
  • Navigation

    Show Sub-Pages | Hide Sub-Pages